Scholz Visit Paves Way For Limited China BioNTech Vaccine Use
Wider Approval To Follow?
Recent visits by foreign dignitaries and progress with local mRNA vaccines and antivirals appear to be helping some slight relaxations in China's strict COVID policies, but some experts predict it may still take months for further steps.
